about
European population substructure: clustering of northern and southern populationsLiver involvement in subjects with rheumatic diseaseApotopes and the biliary specificity of primary biliary cirrhosisSex Differences in the Treatment of Psoriatic Arthritis: A Systematic Literature ReviewInterleukin-1 Inhibition in Behçet's diseaseSerum Islet Cell Autoantibodies During Interferon α Treatment in Patients With HCV-Genotype 4 Chronic HepatitisA sensitive bead assay for antimitochondrial antibodies: Chipping away at AMA-negative primary biliary cirrhosisExpert panel workshop consensus statement on the role of the environment in the development of autoimmune diseaseGenome-wide meta-analyses identify three loci associated with primary biliary cirrhosisLessons learned from twins in autoimmune and chronic inflammatory diseasesClinical follow-up predictors of disease pattern change in anti-Jo1 positive anti-synthetase syndrome: Results from a multicenter, international and retrospective study.Autoimmunity in 2015.Serum Jo-1 Autoantibody and Isolated Arthritis in the Antisynthetase Syndrome: Review of the Literature and Report of the Experience of AENEAS Collaborative Group.Current trends in autoimmunity and the nervous system.Analysis and application of European genetic substructure using 300 K SNP information.Characteristics of splenic CD8+ T cell exhaustion in patients with hepatitis C.The effects of Spirulina on anemia and immune function in senior citizensCommon variable immunodeficiency: etiological and treatment issues.Genomic variants associated with primary biliary cirrhosis.Plasma autoantibodies against heat shock protein 70, enolase 1 and ribonuclease/angiogenin inhibitor 1 as potential biomarkers for cholangiocarcinomaThe prevalence, incidence and natural history of primary sclerosing cholangitis in an ethnically diverse population.The anti-inflammatory properties of cocoa flavanols.Presence of fetal DNA in maternal plasma decades after pregnancy.The autoimmune bases of infertility and pregnancy loss.Primary sclerosing cholangitis in genetically diverse populations listed for liver transplantation: unique clinical and human leukocyte antigen associationsPatients with primary biliary cirrhosis react against a ubiquitous xenobiotic-metabolizing bacterium.Bacteria and human autoimmunity: the case of primary biliary cirrhosis.Autoimmunity and autoinflammation as the yin and yang of idiopathic recurrent acute pericarditis.Antinuclear antibodies in primary biliary cirrhosis.Risk factors and comorbidities in primary biliary cirrhosis: a controlled interview-based study of 1032 patients.The autoimmunity of primary biliary cirrhosis and the clonal selection theory.Epigenetic investigation of variably X chromosome inactivated genes in monozygotic female twins discordant for primary biliary cirrhosis.Monosodium glutamate (MSG): a villain and promoter of liver inflammation and dysplasia.The epigenetics of autoimmunity.Immune-mediated bile duct injury: The case of primary biliary cirrhosis.Diagnostic challenges in celiac disease and the role of the tissue transglutaminase-neo-epitope.Monosodium glutamate (MSG) consumption is associated with urolithiasis and urinary tract obstruction in rats.Quality of life and everyday activities in patients with primary biliary cirrhosis.The search for a practical approach to emerging diseases: the case of severe acute respiratory syndrome (SARS).The Th17 axis in psoriatic disease: pathogenetic and therapeutic implications.
P50
Q21092502-5507897F-96EC-4230-8D1A-2F893200F424Q22000839-A5959881-C398-45CD-8287-96089AD71612Q24646460-6CCB7A8D-07B4-4F48-8A26-54D380229D42Q26745733-F893FDE6-B0DE-41CD-B624-8E00D2CB86D9Q26745741-E5A7C651-5A54-4BFC-AE6D-879E0CEA5E86Q27485587-8887363A-0473-441D-9D1D-712836C0D7BDQ28290430-D31E7533-B3ED-48D3-ACD3-331F3A940A2BQ28394057-4FC1F8E3-7DB9-4498-BB66-ABE9E0E9A2B3Q28943317-140CDC6A-C794-420B-84C5-532E499D6060Q29994578-A380AB5B-9037-445C-9C50-7345A364ACA4Q30238667-601655F9-B079-45F2-B279-71BB5DA57764Q30248983-9A64AA80-506E-4C38-9EC8-D122B1DD6DA7Q30251952-B7A78AA2-E905-42DA-96B0-1572A7B191DFQ31122679-31D5FC57-32F9-45C3-8996-57EC38398583Q33315564-88510123-1CA0-497E-B357-F6C518801694Q33408423-39BDF657-3A49-45DB-86A8-2B0ADF46E66BQ33577492-AC20527D-DA2C-467B-930F-725E89432E82Q33621805-B985446C-63E9-4473-BE92-5FEE0C0F29F8Q33693726-EE5C5BA3-AA3C-41C0-B37E-3EC24C8BAAABQ33945955-91699F55-9D7C-4378-81B7-77CC89FB097CQ33964509-7B37F880-9E8C-4232-8430-D40AD365A420Q33997075-CE12C02F-7B01-4CA7-867A-659C9086C580Q34137715-33252155-E062-4F79-AB35-BCA01F6503CCQ34250224-1FFD6729-EB2F-4DED-AB8A-279BFC9C8496Q34257876-E6B36C12-3453-4FE3-8C25-E25EB1AEE34DQ34272356-5697AE14-6CB8-4418-A032-387E3AD04E5BQ34327472-17A35CBC-1924-48E1-BEBE-F2B0B89AE6E7Q34443117-715C9902-9EFB-41A3-93D1-B8D9C775E2CAQ34448645-5D457033-677C-4E1A-8AA6-989E71B6734EQ34462959-9EC8630F-1BDF-4BD3-A1E9-C5F51E8ADC45Q34472336-9A215980-0BD6-4A38-A566-0D09008A1B7FQ34532730-D10F3043-AAD5-43E5-A058-56788067646CQ34733576-3AC54707-EA66-4EF2-A436-DCF1D16E3F92Q34979322-86C54121-CC83-46E2-A983-ECBB68D8BFBBQ34992359-347AA489-D842-4871-8CFB-FBDACD115262Q34993879-11989429-310E-4E92-974A-D72CE365AEC4Q35005731-46F22D20-B973-42ED-A193-C0ADA428C7ABQ35142961-76CD99B6-23F5-4785-ABD3-3FC5EFF83E71Q35186575-75E30C22-2F26-44F3-B2BA-D40BCAD80BD8Q35308947-13A2E64A-E7A3-4BA9-B502-6CE7A69CB84A
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Carlo Selmi
@ast
Carlo Selmi
@en
Carlo Selmi
@es
Carlo Selmi
@nl
Carlo Selmi
@sl
type
label
Carlo Selmi
@ast
Carlo Selmi
@en
Carlo Selmi
@es
Carlo Selmi
@nl
Carlo Selmi
@sl
prefLabel
Carlo Selmi
@ast
Carlo Selmi
@en
Carlo Selmi
@es
Carlo Selmi
@nl
Carlo Selmi
@sl
P106
P1153
6701520362
P21
P31
P496
0000-0002-0323-0376